News
GTBIF
13.17
-1.42%
-0.19
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
US Drug Enforcement Administration will reschedule cannabis from a Schedule 1 drug to a Schedule 3. The proposed rescheduling of cannabis is the biggest step forward for the cannabis industry in decades. Most cannabis companies will see immediate financial and operational benefits from the move. Cannabis has been in a bull market since last August.
Seeking Alpha · 23h ago
Nasdaq finally ‘warming up’ to Canadian cannabis companies with U.S. exposure. Could American growers be next?
MarketWatch · 1d ago
EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
Benzinga's cannabis stock expert, Michael Berger says the cannabis market is just getting started. The DEA's decision to move marijuana from Schedule I to Schedule III left cannabis stocks soaring on Tuesday. The 19th Benzinga Cannabis Capital Conference is returning to Chicago this Oct. 8-9.
Benzinga · 1d ago
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
The DEA's decision to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators. Viridian Capital Advisors' analysis says several MSOs are navigating different financial paths post-DEA rescheduling. The MSO index surged by 25% immediately after the announcement.
Benzinga · 1d ago
LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates
NASDAQ · 2d ago
Marijuana opposition group raising money to fight cannabis rescheduling
Anti-marijuana reform group raising money to fight cannabis rescheduling. Smart Approaches to Marijuana opposes the DEA's reported decision to reschedule cannabis as a less dangerous drug. The group says the move would give Big Marijuana billions in tax write-offs. The proposed rescheduled cannabis still needs to go through White House review.
Seeking Alpha · 2d ago
Cannabis banking reform bolstered by new poll
A new poll commissioned by a banking group finds that a majority of Americans support legislation that would allow cannabis businesses to access the U.S. Financial system. 64% of Americans say the legislation would help improve public safety. 54% say opening the banking system to cannabis businesses would help underserved communities.
Seeking Alpha · 2d ago
Marijuana Stock Movers For May 1, 2024
Global Hemp Group shares closed up 86.36% at $0.04. AusCann Group Holdings (OTC:ACNNF) shares closed down 69.60%. Canopy Gwth shares down 25.67%. Cronos Group (NASDAQ:CRON) shares down 7.82%.
Benzinga · 3d ago
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
The DEA is moving towards rescheduling cannabis from Schedule I to Schedule III. The total economic impact generated by regulated marijuana sales in the U.S. Is estimated to surpass $112.4 billion in 2024. Since 2018, major players in the cannabis industry have experienced fluctuating market capitalizations. The economic impact of every dollar spent on legal marijuana is expected to reach over $200 billion by 2030.
Benzinga · 3d ago
DEA Moves To Reschedule Weed, Cannabis Stocks Go For Wild Ride, Pummel Short Sellers With $210M In Losses
Cannabis stocks soared on Tuesday after the DEA announced plans to move marijuana from Schedule I to Schedule III. Short sellers with positions against the top 10 cannabis company stocks took up to $210 million in losses. The expected changes in the tax law will allow cannabis companies to write off standard deductions.
Benzinga · 3d ago
Schumer eyes more cannabis reforms after ‘historic’ marijuana rescheduling decision
Senate Majority Leader Chuck Schumer says he remains committed to even more cannabis reforms. The U.S. Drug Enforcement Administration announced it plans to reclassify marijuana to a less restrictive category called Schedule III. The decision falls short of marijuana legalization, a cause Schumer has long championed.
Seeking Alpha · 3d ago
BUZZ-Pot stocks drop, after surging to months high following marijuana reclassification move
Pot stocks drop after surging to months high following marijuana reclassification move. U.S. DOJ moved to reclassify cannabis as a less dangerous drug on Tuesday. Pot firms Canopy Growth and Aurora Cannabis down 21% and 27%. Morningstar analyst says drop may be due to people taking money off the table.
Reuters · 3d ago
Pot stocks rally snuffed day after DEA marijuana rescheduling development
Consumer pot stocks rally snuffed day after DEA marijuana rescheduling development. U.S. Multi-state operators hardest hit are Ayr Wellness and Trulieve Cannabis. Canopy Growth is the worst performer, down 29%. Most Canadian cannabis licensed producers are also struggling.
Seeking Alpha · 3d ago
Canopy Growth Stock: Expect A Crash After The High
Shares of cannabis companies soared after news that the US DEA is considering reclassifying marijuana as a Schedule III drug. Canopy Growth Corporation saw the biggest increase, with CGC stock closing up 78.9%. Canopy growth faces financial challenges, including debt, cash outflows, and declining revenue.
Seeking Alpha · 3d ago
OMB review of cannabis rescheduling could put measure at risk
White House Office of Management and Budget review of cannabis rescheduling could scuttle the reform. Review could take 70 days to complete. The DEA's likely reclassification of marijuana from a Class I to a Class III controlled substance could be delayed until after the election.
Seeking Alpha · 3d ago
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains?
NASDAQ · 3d ago
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug. Shares of cannabis companies surged on Tuesday afternoon. DoJ recommended that cannabis be classified as a schedule three drug. The reclassification will legalize marijuana outright for recreational use.
Reuters · 4d ago
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The DEA moved marijuana from Schedule I to Schedule III under the Controlled Substances Act. The DEA's decision aligns with a recommendation from the Department of Health and Human Services to reschedule cannabis. The cannabis sector saw a notable upswing on Tuesday after the announcement.
Benzinga · 4d ago
Pot stocks surge on news of cannabis rescheduling
Pot stocks surge on news of cannabis rescheduling. The DEA is set to reclassify marijuana as a less dangerous drug. U.S. Multi-state operators have recorded double-digit percentage gains. Cannabis-related stocks rose sharply higher in afternoon trading Tuesday.
Seeking Alpha · 4d ago
Cannabis stocks rally after report that DEA will reclassify drug as less dangerous
MarketWatch · 4d ago
More
Webull provides a variety of real-time GTBIF stock news. You can receive the latest news about Green Thum through multiple platforms. This information may help you make smarter investment decisions.
About GTBIF
Green Thumb Industries Inc, formerly Bayswater Uranium Corporation, is a cannabis cultivator, dispensary operator and consumer packaged goods company. The Company's branded cannabis products includes Beboe, Dogwalkers, Dr. Solomon's, incredibles, Rythm and The Feel Collection. The Company owns and operates a chain of retail cannabis stores called RISE dispensaries. The Company operates 15 manufacturing facilities and licenses for approximately 110 retail locations across 13 United States markets.